London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...

“I believe we've hit not only the cell of origin for lung adenocarcinoma, but also the pathway of origin,” says Kadara. This cancer originates in the epithelial cells that line the lung’s ...

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have ...

Endocrine Neoplasia Translational Research Center, Division of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, and Tel Aviv University Faculty of Medicine, Ramat Gan, Israel This ...

This is an important piece of work that sheds light on our understanding of early lung development. There is solid evidence that there is a key new role for Svep1, which may be acting via FGF9. A more ...

Keratin can highlight epithelial cells to determine the location of an infiltrate. This is important in an atelectatic lung specimen when it is difficult to be sure whether a cellular infiltrate ...

Red blood cells and epithelial cells should be enumerated but are not included in the total white cell count. Differential cell counts are most frequently determined on slides prepared either by ...

CyPath Lung is a laboratory-developed assay that uses self-collected sputum samples treated with a fluorescent compound that preferentially binds to cancer cells and cancer-related cells, San ...

ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...

决定依据《国家自然科学基金项目科研不端行为调查处理办法》第五十条第一项、第四项和第四十四条第四项，取消全成国家自然科学基金项目评审专家资格3年（2024年4月9日至2027年4月8日），取消全成国家自然科学基金项目申请和参与申请资格2年（2024年4月9日至2026年4月8日），给予全成通报批评。